7-141551244-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NR_183408.1(AGK-DT):n.101G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0925 in 152,302 control chromosomes in the GnomAD database, including 1,420 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.092 ( 1420 hom., cov: 32)
Exomes 𝑓: 0.043 ( 0 hom. )
Consequence
AGK-DT
NR_183408.1 non_coding_transcript_exon
NR_183408.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.19
Genes affected
AGK-DT (HGNC:55356): (AGK divergent transcript)
AGK (HGNC:21869): (acylglycerol kinase) The protein encoded by this gene is a mitochondrial membrane protein involved in lipid and glycerolipid metabolism. The encoded protein is a lipid kinase that catalyzes the formation of phosphatidic and lysophosphatidic acids. Defects in this gene have been associated with mitochondrial DNA depletion syndrome 10. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 7-141551244-C-G is Benign according to our data. Variant chr7-141551244-C-G is described in ClinVar as [Benign]. Clinvar id is 1329639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGK-DT | NR_183408.1 | n.101G>C | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGK-DT | ENST00000567503.1 | n.61G>C | non_coding_transcript_exon_variant | 1/4 | 3 | |||||
AGK-DT | ENST00000668372.1 | n.29G>C | non_coding_transcript_exon_variant | 1/3 | ||||||
AGK | ENST00000629555.2 | upstream_gene_variant | 5 | ENSP00000487274 |
Frequencies
GnomAD3 genomes AF: 0.0921 AC: 14019AN: 152140Hom.: 1410 Cov.: 32
GnomAD3 genomes
AF:
AC:
14019
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0435 AC: 2AN: 46Hom.: 0 Cov.: 0 AF XY: 0.0250 AC XY: 1AN XY: 40
GnomAD4 exome
AF:
AC:
2
AN:
46
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
40
Gnomad4 AFR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0925 AC: 14080AN: 152256Hom.: 1420 Cov.: 32 AF XY: 0.0915 AC XY: 6809AN XY: 74444
GnomAD4 genome
AF:
AC:
14080
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
6809
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 21, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at